| [1] |
Podhajcer OL,Benedetti L,Girotti MR,et al.The role of the matricellular protein SPARC in the dynamicinteraction between the tumor and the host[J].Cancer Metastasis Rev,2008,27(3):523-37.
|
| [2] |
Nagaraju GP,Sharma D.Anti-cancer role of SPARC,an inhibitor of adipogenesis[J].Cancer Treat Rev,2011,37(7):559-66.
|
| [3] |
Witkiewicz AK,Freydin B,Chervoneva I,et al.Stromal CD10 and SPARC expression in ductal carcinoma in situ(DCIS) patients predicts disease recurrence[J].Cancer Biol Ther,2010,10(4):391-6.
|
| [4] |
Xue LY,Hu N,Song YM.Tissue microarray analysis reveals a tight correlation between protein expressionpattern and progression of esophageal squamous cell carcinoma[J].BMC Cancer,2006,6:296.
|
| [5] |
Che YQ,Wang H,Qi J,et al.The analysis of the SPARC protein expression and clinical significance inesophageal squamous cell carcinoma[J].Zhongguo Zhong Liu Lin Chuang,2006,33(2):61-3.[车秩群,王海,齐军,等.食管鳞癌组织中SPARC蛋白表达的临床意义[J].中国肿瘤临床,2006,33(2):61-3.]
|
| [6] |
Nagai MA,Gerhard R,Fregnani JH,et al.Prognostic value of NDRG1 and SPARC protein expression in breast cancerpatients[J].Breast Cancer Res Treat,2011,126(1):1-14.
|
| [7] |
Luo KJ,Hu Y,Wen J.et al.CyclinD1,p53,E-cadherin,and VEGF discordant expression in paired regional metastaticlymph nodes of esophageal squamous cell carcinoma:A tissue array analysis[J].J Surg Oncol,2011,104(3):236-43.
|
| [8] |
Piao JM,Kim HN,Song HR,et al.p53 codon 72 polymorphism and the risk of esophageal cancer:a Korean case-control study[J].Dis Esophagus,2011,24(8):596-600.
|
| [9] |
Jiang DK,Yao L,Wang WZ,et al.TP53 Arg72Pro polymorphism is associated with esophageal cancer risk:a meta-analysis[J].World J Gastroenterol,2011,17(9):1227-33.
|
| [10] |
Umar M,Upadhyay R,Khurana R,et al.Role of p53 and p73 genes polymorphisms in susceptibility to esophagealcancer:a case control study in a northern Indian population[J].Mol Biol Rep,2012,39(2):1153-62.
|
| [11] |
Tanaka K,Yano M,Motoori M,et al.CEA-antigen and SCC-antigen mRNA expression in peripheral blood predicthematogenous recurrence after resection in patients with esophageal cancer[J].Ann Surg Oncol,2010,17(10):2779-86.
|
| [12] |
ukaszewicz-Zajac M,Mroczko B,Kozowski M,et al.Elevated levels of serum metalloproteinase 9 in patientswith esophageal squamous cell carcinoma[J].Pol Arch Med Wewn,2009,119(9):558-63.
|
| [13] |
Yi Y,Li B,Wang Z,et al.CYFRA21-1 and CEA are useful markers for predicting the sensitivity tochemoradiotherapy of esophageal squamous cell carcinoma[J].Biomarkers,2009,14(7):480-5.
|
| [14] |
Dong J,Zeng BH,Xu LH，et al.Anti-CDC25B autoantibody predicts poor prognosis in patients with advancedesophageal squamous cell carcinoma[J].J Transl Med,2010,8:81.
|
下载:
